Additionally, it emphasizes the roles and mechanisms of the NLRP3 inflammasome in common inflammation-related gastrointestinal diseases such as ulcerative colitis, Crohn’s disease, pancreatitis, and non-alcoholic fatty liver disease (NAFLD). Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.